A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LEDD / levodopa equivalent daily dose

[Related PubMed/MEDLINE]
Total Number of Papers: 146
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LEDD  (>> Co-occurring Abbreviation)
Long Form:   levodopa equivalent daily dose
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Association between sleep disturbances and pain subtypes in Parkinson's disease. ADL, HAM-A, HAM-D, KPPS, MMSE, PD, PSQI, UPDRS-III, VAS
2022 Electrode Fixation with Bone Cement or Stimloc® in Deep Brain Stimulation Surgery: A Comparative Study. DBS, PD, STN, UPDRS
2022 Energy Delivered by Subthalamic Deep Brain Stimulation for Parkinson Disease Correlates With Depressive Personality Trait Shift. CAPSIT-PD, MMPI-2, PD, STN-DBS, TEED
2022 Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait. BMI, FOG, FOG-Q, HY, MNA, PD, PD-NMS, PDFOG, TC, UPDRS-III
2022 Longitudinal Prediction of Freezing of Gait in Parkinson's Disease: A Prospective Cohort Study. FOG, OR, PD
2022 Pain Assessment in Chinese Parkinson's Disease Patients Using King's Parkinson's Disease Pain Scale. ADL, HAM-A, HAM-D, KPPS, MMSE, PD, PSQI, UPDRS-III, VAS
2022 Single-Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa-Carbidopa Intestinal Gel. LCIG, PD
2022 Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson's disease. HAM-A, HAM-D, PD, SCOPA-Aut, STN-DBS, UPDRS
2021 A Cross-Sectional Comprehensive Assessment of the Profile and Burden of Non-motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort. NMS, NMSS, NPDR, PD, PIGD
10  2021 A prospective pilot study of the effects of deep brain stimulation on olfaction and constipation in Parkinson's disease. CBSM, UPSIT
11  2021 Choroidal Thickness Correlates with Clinical and Imaging Metrics of Parkinson's Disease: A Pilot Study. PD, QSM, SNc
12  2021 Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol. CR, EEG, FOG, MDS-UPDRS, STN, vCR, VTDT
13  2021 Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease. DBS, GPi, IPD, LRRK2-PD, STN
14  2021 Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson's disease. DBS, ET, GPi, PD, STN, UPDRS, VIM
15  2021 Constructing Prediction Models for Freezing of Gait by Nomogram and Machine Learning: A Longitudinal Study. ADL, C-index, COMT, ESS, FOG, HDRS, NMSS, PD, PDSS, PFS, RBDQ-HK, RF, TD, UPDRS
16  2021 Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson's disease. CCM, CNBD, CNFD, CNFL, MoCA, PD, PD-CN, UPDRS
17  2021 Dizziness in Parkinson's disease patients is associated with vestibular function. K-MMSE, PD, UPDRS, VEMPs
18  2021 Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity. DBS, PD, STN
19  2021 Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease. DBS, PD, STN, UDysRS, UPDRS-III
20  2021 Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson's Disease as measured by the non-motor symptoms scale. DBS, HY, NMS, NMSS, PD, PDSS, SCOPA, STN
21  2021 Excessive daytime sleepiness in Parkinson's disease: A systematic review and meta-analysis. EDS, HY, PD, UPDRS
22  2021 Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis. CIs, HP, ORs, PD, SMDs
23  2021 Impact of Procedural Sedation on the Clinical Outcome of Microelectrode Recording Guided Deep Brain Stimulation in Patients with Parkinson's Disease. DBS, LA, MDS-UPDRS III, PD, PSA, STN
24  2021 Impact of Progression of Parkinson's Disease on Swallowing Ability and Oral Environment. MBF, OBC, PD, SDQ, TP, UPDRS
25  2021 Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease. MMSE, PD, REM, RWA, UPDRS, vPSG
26  2021 Lateralization of Motor Signs Affects Symptom Progression in Parkinson Disease. LPD, NLPD, PDBP, PDQ-39
27  2021 Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson's Disease. DAT, FOG, NPI, NPS, PD
28  2021 Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease. NMSS, PD, PDQ-8, QoL, SCOPA, STN-DBS
29  2021 Predictors of Pain Severity and its Impact on Quality of Life in Patients with Parkinson's Disease. KPPS, PD, PDQ-8, QoL, UPDRS
30  2021 Prevalence and associated factors of malnutrition in patients with Parkinson's disease using CONUT and GNRI. BMI, CONUT, GNRI, HC, PD
31  2021 Prevalence of malnutrition/malnutrition risk and nutrition-related risk factors among patients with Parkinson's disease: systematic review and meta-analysis. CI, MNA, PwP, UPDRS
32  2021 Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease. MNI, PD, UPDRS-III, VTA
33  2021 Short- and long-term motor outcome of STN-DBS in Parkinson's Disease: focus on sex differences. PD, STN-DBS
34  2021 Sleep problems affect quality of life in Parkinson's disease along disease progression. HRQoL, NMS, PD, PDQ39, PDSS-2, UPDRS
35  2021 Stability of MDS-UPDRS Motor Subtypes Over Three Years in Early Parkinson's Disease. AUC, CI, MDS-UPDRS, OR, PALS, PD, PIGD, TD
36  2021 Subthalamic and pallidal deep brain stimulation for Parkinson's disease-meta-analysis of outcomes. AE, DBS, GPi, PD, STN, UPDRS
37  2021 The Accuracy of Direct Targeting Using Fusion of MR and CT Imaging for Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson's Disease. CT, DBS, ED, MER, MRI, PD, STN, UPDRS-III
38  2021 The clinical meaning of levodopa equivalent daily dose in Parkinson's disease. L-dopa, PD
39  2021 Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study. AR, MDS-UPDRS, PD
40  2021 [Measurement of corneal nerve fiber parameters in patients with Parkinson's disease]. CCM, CNBD, CNFD, CNFL, HY stage, PD, ROC, UPDRS
41  2020 A 3-year observation of excessive daytime sleepiness after subthalamic deep brain stimulation in patients with Parkinson's disease. EDS, ESS, PD, PDSS, STN-DBS
42  2020 A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan. APM, DBS, dTM, iTM, LED, medON, PD, Stim ON, STN, UPDRS
43  2020 A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up. MED, NMS, NMSS, PD, PDQ-8, SCOPA, STN-DBS
44  2020 Aberrant Amplitude of Low-Frequency Fluctuations in Different Frequency Bands in Patients With Parkinson's Disease. ALFF, HCs, HY, ITG/FG, MCC, PD, R-fMRI
45  2020 Analysis of factors associated with brittle response in patients with Parkinson's disease. BR, LID, NBR, PD, RBD
46  2020 Analysis of Motor Complication and Relative Factors in a Cohort of Chinese Patients with Parkinson's Disease. PD
47  2020 Asleep Surgery May Improve the Therapeutic Window for Deep Brain Stimulation of the Subthalamic Nucleus. DBS, PD, STN, TW, UPDRS-III
48  2020 Assessment of Wearing Off in Parkinson's disease using objective measurement. PD, PTB, PwP, WO
49  2020 Association between dopaminergic medications and REM sleep behavior disorder in Parkinson's disease: a preliminary cohort study. DRTs, PD, RBD, RBDSQ
50  2020 Association Between Nonmotor Symptoms and Nonadherence to Medication in Parkinson's Disease. BDI-II, NMS, NMSQ, PD, SAMS
51  2020 Association of Serum Indirect Bilirubin Concentrations with Motor Subtypes of Parkinson's Disease. DBIL, IBIL, PD, PIGD, TBIL, TD
52  2020 Beneficial effect of 24-month bilateral subthalamic stimulation on quality of sleep in Parkinson's disease. DBS, PD, PDQ-8, PDSS, QoL, STN
53  2020 Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease. DBS, NMS, NMSS, PD, PDQ
54  2020 Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan. ER, IR, MPR
55  2020 Clinical outcomes of globus pallidus deep brain stimulation for Parkinson disease: a comparison of intraoperative MRI- and MER-guided lead placement. DBS, GPi, iMRI, MER, PD, UPDRS
56  2020 Effect of Olfactory and Gustatory Dysfunction and Motor Symptoms on Body Weight in Patients with Parkinson's Disease. PD, UPDRS
57  2020 Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease. PD, SNc, STN-DBS
58  2020 Intraoperative Neurophysiologic Assessment in Deep Brain Stimulation Surgery and its Impact on Lead Placement. AE, DBS, DSP, MER, MS, PSP, UPDRS-III
59  2020 Is dopaminergic medication dose associated with self-reported bruxism in Parkinson's disease? A cross-sectional, questionnaire-based study. PD, TMD
60  2020 Longitudinal medication profile and cost savings in Parkinson's disease patients after bilateral subthalamic nucleus deep brain stimulation. ---
61  2020 Non-motor Symptoms in Parkinson's Disease Patients with Parkin Mutations: More Depression and Less Executive Dysfunction. AOO, BDI, EOPD, GU, GU group, NMSs, PD, TMT
62  2020 Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial. UPDRS
63  2020 Orofacial dystonia and asssociated bulbar symptoms in multiple system atrophy: A blinded video analysis. MSA, OFD, OMD
64  2020 Risk factors for minor hallucinations in Parkinson's disease. aMHs, MHs, OR, PD, RBD
65  2020 Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson's Disease. BDI-II, MoCA, NMSQ, PD, SAMS
66  2020 Sex Disparities in the Self-Evaluation of Subthalamic Deep Brain Stimulation Effects on Mood and Personality in Parkinson's Disease Patients. BDI-I, DBS, PD, QoL, STN
67  2020 The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population. BoProPark
68  2020 [Application of intracranial lead reconstruction in deep brain stimulation therapy in patients with Parkinson's disease]. DBS, PD, SEADL, STN
69  2019 Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis. STN-DBS, UPDRS-III
70  2019 Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. FDR, HR, MCI, NC, PD, PDBP, RFUs, UPenn
71  2019 Clinical correlates of repetitive speech disorders in Parkinson's disease. MoCA, PD, UPDRS-III
72  2019 Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population. DBS, HAM-D, MMSE, PD, STN, UPDRS
73  2019 EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. APO, IJLI, NMS, NMSS, PD, UPDRS
74  2019 Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China. PD
75  2019 Focal Vibration Training (Equistasi) to Improve Posture Stability. A Retrospective Study in Parkinson's Disease. BBS, FVT, PD, RP, TUG, UPDRS
76  2019 Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. CI, GEEs, PTSD, VA
77  2019 Impact of subthalamic nucleus stimulation did not differ on young-onset and older-onset Parkinson's disease: A three-year follow up. STN-DBS, UPDRS-III
78  2019 L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression. PD
79  2019 Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson's disease. AS, FU, LCIG, PD
80  2019 Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale. DBS, HY, PD, UPDRS-III
81  2019 Pisa Syndrome in Chinese Patients With Parkinson's Disease. FAB, HAMA, HAMD, MoCA, PD, PS, UPDRS
82  2019 Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease. LDD, PD, STN-DBS
83  2019 Quality of life in patients with Parkinson's disease after subthalamic stimulation: An observational cohort study for outcome prediction. HRQoL, PD, PDQ-39, STN-DBS, UPDRS
84  2019 The Characteristics of Patients Associated With High Caregiver Burden in Parkinson's Disease in Singapore. PD, QoL
85  2019 The effect of postural deformities on back function and pain in patients with Parkinson's disease. BPI, ODI, PS, PwPD, UPDRS
86  2019 The influence of postural deformities on neck function and pain in patients with Parkinson's disease. BPI, NDI, PD, PS, PwPD, UPDRS
87  2019 Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease. CRW, DBS, MDS-UPDRS, PD, STN
88  2018 A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease. DBS, ICDs, mMIDI, PD, STN
89  2018 Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease. AES, DBS, HADS, PD, PDQ-8, QoL, SRMI, STN, UPDRS
90  2018 Bilateral subthalamic deep brain stimulation is an effective and safe treatment option for the older patients with Parkinson's disease. DBS, PD, STN, UPDRS
91  2018 Circadian rhythms and influencing factors of xerostomia among Parkinson's disease patients. PD, VAS
92  2018 Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. DBS, GPi, MER, PD, STN, UPDRS-III
93  2018 Comparison of Awake vs. Asleep Surgery for Subthalamic Deep Brain Stimulation in Parkinson's Disease. DBS, PD, STN, UPDRS-III
94  2018 Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up. DBS, PD, UPDRS-III
95  2018 Deep Brain Stimulation in Moroccan Patients With Parkinson's Disease: The Experience of Neurology Department of Rabat. DBS, QoL, STN
96  2018 Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson Disease with Prior Pallidotomy or Thalamotomy. PD, UPDRS-III
97  2018 Does Pisa syndrome affect upper limb function in patients with Parkinson's disease? An observational cross-sectional study. DASH, HC, PD, PS, UL, UPDRS
98  2018 Effect of unilateral subthalamic deep brain stimulation in highly asymmetrical Parkinson's disease: 7-year follow-up. DBS, HY, PD, STN, UPDRS-III
99  2018 Levodopa Effect and Motor Function in Late Stage Parkinson's Disease. HY, L-dopa, PD, PKG, UPDRS
100  2018 Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease. LCIG, PD, WL